Syndax Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript
Good afternoon, and thank you all for joining us. This is Konstantinos Aprilakis. I recently joined the health care equity research team here at Stifel, as a senior biotech analyst. It's my pleasure to introduce Dr. Briggs Morrison, CEO of Syndax. The Syndax team have kindly prepared a brief corporate presentation for us.
Please note that this session will not feature a live Q&A. We ask that you submit any questions for the company directly to our corporate access team via e-mail that can be reached at [email protected]. That's all one word, [email protected]. And with that, I'll turn it over to you, Briggs.
Thanks so much, Konstantin. Pleasure to be here today to tell you -- bring you up-to-date on where we are in our corporate journey. Let me start with our forward look statement. Again, you can reference our SEC documents to see all the various
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
